BACKGROUND: Most reported human H5N1 viral infections have been severe and were detected after hospital admission. A case ascertainment bias may therefore exist, with mild cases or asymptomatic infections going undetected. We sought evidence of mild or asymptomatic H5N1 infection by examining H5N1-specific T-cell and antibody responses in a high-risk cohort in Vietnam. METHODS: Peripheral blood mononuclear cells were tested using interferon-γ enzyme-linked immunospot T assays measuring the response to peptides of influenza H5, H3, and H1 hemagglutinin (HA), N1 and N2 neuraminidase, and the internal proteins of H3N2. Horse erythrocyte hemagglutination inhibition assay was performed to detect antibodies against H5N1. RESULTS: Twenty-four of 747 individuals demonstrated H5-specific T-cell responses but little or no cross-reactivity with H3 or H1 HA peptides. H5N1 peptide-specific T-cell lines that did not cross-react with H1 or H3 influenza virus HA peptides were generated. Four individuals also had antibodies against H5N1. CONCLUSIONS: This is the first report of ex vivo H5 HA-specific T-cell responses in a healthy but H5N1-exposed population. Our results indicate that the presence of H5N1-specific T cells could be an additional diagnostic tool for asymptomatic H5N1 infection.
BACKGROUND: Most reported human H5N1 viral infections have been severe and were detected after hospital admission. A case ascertainment bias may therefore exist, with mild cases or asymptomatic infections going undetected. We sought evidence of mild or asymptomatic H5N1 infection by examining H5N1-specific T-cell and antibody responses in a high-risk cohort in Vietnam. METHODS: Peripheral blood mononuclear cells were tested using interferon-γ enzyme-linked immunospot T assays measuring the response to peptides of influenza H5, H3, and H1 hemagglutinin (HA), N1 and N2 neuraminidase, and the internal proteins of H3N2. Horse erythrocyte hemagglutination inhibition assay was performed to detect antibodies against H5N1. RESULTS: Twenty-four of 747 individuals demonstrated H5-specific T-cell responses but little or no cross-reactivity with H3 or H1 HA peptides. H5N1 peptide-specific T-cell lines that did not cross-react with H1 or H3 influenza virus HA peptides were generated. Four individuals also had antibodies against H5N1. CONCLUSIONS: This is the first report of ex vivo H5 HA-specific T-cell responses in a healthy but H5N1-exposed population. Our results indicate that the presence of H5N1-specific T cells could be an additional diagnostic tool for asymptomatic H5N1 infection.
Authors: Hien T Nguyen; Nila J Dharan; Mai T Q Le; Nguyen B Nguyen; Chung T Nguyen; Dong V Hoang; Huu N Tran; Chien T Bui; Dat T Dang; Dinh N Pham; Hoa T Nguyen; Tu V Phan; David T Dennis; Timothy M Uyeki; Joshua Mott; Yen T Nguyen Journal: Vaccine Date: 2009-10-21 Impact factor: 3.641
Authors: J H C M Kreijtz; G de Mutsert; C A van Baalen; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan Journal: J Virol Date: 2008-03-19 Impact factor: 5.103
Authors: Jenny Aurielle B Babon; John Cruz; Laura Orphin; Pamela Pazoles; Mary Dawn T Co; Francis A Ennis; Masanori Terajima Journal: Hum Immunol Date: 2009-06-11 Impact factor: 2.850
Authors: Jenni M Vuola; Sheila Keating; Daniel P Webster; Tamara Berthoud; Susanna Dunachie; Sarah C Gilbert; Adrian V S Hill Journal: J Immunol Date: 2005-01-01 Impact factor: 5.422
Authors: Tao Dong; Guillaume Stewart-Jones; Nan Chen; Philippa Easterbrook; Xiaoning Xu; Laura Papagno; Victor Appay; Michael Weekes; Chris Conlon; Celsa Spina; Susan Little; Gavin Screaton; Anton van der Merwe; Douglas D Richman; Andrew J McMichael; E Yvonne Jones; Sarah L Rowland-Jones Journal: J Exp Med Date: 2004-12-13 Impact factor: 14.307
Authors: Menno D de Jong; Cameron P Simmons; Tran Tan Thanh; Vo Minh Hien; Gavin J D Smith; Tran Nguyen Bich Chau; Dang Minh Hoang; Nguyen Van Vinh Chau; Truong Huu Khanh; Vo Cong Dong; Phan Tu Qui; Bach Van Cam; Do Quang Ha; Yi Guan; J S Malik Peiris; Nguyen Tran Chinh; Tran Tinh Hien; Jeremy Farrar Journal: Nat Med Date: 2006-09-10 Impact factor: 53.440
Authors: Jean-Michel Garcia; Stephanie Pepin; Nadège Lagarde; Edward S K Ma; Frederick R Vogel; Kwok H Chan; Susan S S Chiu; J S M Peiris Journal: PLoS One Date: 2009-11-20 Impact factor: 3.240
Authors: Eric S Toner; Amesh A Adalja; Jennifer B Nuzzo; Thomas V Inglesby; Donald A Henderson; Donald S Burke Journal: Clin Infect Dis Date: 2013-02-05 Impact factor: 9.079
Authors: Timothy J Powell; Yanchun Peng; Tamara K Berthoud; Marie-Eve Blais; Patrick J Lillie; Adrian V S Hill; Sarah L Rowland-Jones; Andrew J McMichael; Sarah C Gilbert; Tao Dong Journal: PLoS One Date: 2013-05-03 Impact factor: 3.240